How to Profit From Increasing Obesity: Sanofi SA (ADR) (SNY), Novo Nordisk A/S (ADR) (NVO), Covidien plc (COV)
Funnily enough, I think that long term investors should be investing in the long term.
Posts Tagged ‘Sanofi Aventis (SNY)’
Merrimack Pharmaceuticals Inc (MACK) May Be Right For Your Portfolio
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) may be the perfect biotech company for your speculative portfolio.
Better Health, an iPhone App Away: Sanofi SA (ADR) (SNY), Johnson & Johnson (JNJ)
An Apple a day might not keep the doctor away, but the company's AppStore carries several solutions for tracking health care on the go -- and pharmaceutical companies continue...
Is Bristol-Myers Squibb Co. (BMY) One of the Best Companies in America?
The Motley Fool recently published its list of The 25 Best Companies in America and while Bristol-Myers Squibb Co.
Is Merck & Co., Inc. (MRK) One of the Best Companies in America?
The Motley Fool recently whittled down 1,700 public companies to name its list of The 25 Best Companies in America. Merck & Co., Inc.
3 Humongous Health-Care Stocks This Week: Celgene Corporation (CELG), Celldex Therapeutics, Inc. (CLDX)
The Dow set an all-time high, but it still was up only 2% for the week. If you want returns to really get excited about, look no further than the health-care sector.
Pharmaceutical Winners And Losers In Early 2013: Johnson & Johnson (JNJ), Sanofi SA (ADR) (SNY), Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
Ultimately, that was the loss of those optimists. As value investors, we are not afraid of bad news as long as we get compensated by low valuations.
Analyst Roundtable: Any Surprises in Amarin Corporation plc (ADR) (AMRN)’s Fourth Quarter?
Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to discuss Amarin Corporation plc (ADR) (NASDAQ:AMRN) , a biotech that recently launched...
What Stocks Are in Buffett’s Annual Letter? – Wells Fargo & Co (WFC), The Procter & Gamble Company (PG)
Okay, Okay! Another ‘Warren Buffett buys this, Buffett buys that’ article.
Thinking Smaller Is Big for Big Pharma: Eli Lilly & Co. (LLY), Sanofi SA (ADR) (SNY), Bristol Myers Squibb Co. (BMY)
Do good things come in small packages for big pharma? Most of investors' attention is given to blockbuster drugs and drugs that have the potential to be blockbusters.
Johnson & Johnson (JNJ), Dendreon Corporation (DNDN) – Tackling Cancer: Prostate Cancer’s Biggest Current and Upcoming Players
As I commented last week, cancer statistics are both staggering and disappointing.
Can’t-Miss Health-Care Events This Week: GlaxoSmithKline plc (ADR)(GSK), Theravance Inc (THRX)
On Monday, Depomed Inc (NASDAQ:DEPO) is expected to go before the FDA panel with its menopausal hot-flash drug, Serada.
Who’s the Frailest Big Pharma of All? – Bristol Myers Squibb Co. (BMY), Pfizer Inc. (PFE), Sanofi SA (ADR) (SNY)
Mirror, mirror, on the wall, who's the frailest big pharma of all? The patent cliff has certainly taken its toll over the past couple of years, weakening several successful pharmaceutical...
How Novo Nordisk A/S (ADR) (NVO) Will Deal With A Diabetes Delay: Sanofi SA (ADR) (SNY), Johnson & Johnson (JNJ)
Novo Nordisk A/S (ADR) (NYSE:NVO) recently got some bad news from the Food and Drug Administration: a request for additional information about a key insulin product.
Billionaire Ken Fisher’s Dividend Picks Include Philip Morris
Fisher Asset Management, a fund managed by billionaire (and author and Forbes columnist) Ken Fisher, filed its 13F for the fourth quarter of last year in January.
Warren Buffett’s Dividend Stocks Include Procter & Gamble
Warren Buffett of Berkshire Hathaway is recognized as one of the greatest long-term investors of all time.
Battle of the Pharma Dividends: Bristol Myers Squibb Co. (BMY) vs. Eli Lilly & Co. (LLY)
Are Bristol Myers Squibb Co. (NYSE:BMY) and Eli Lilly & Co.
Novo Nordisk A/S (ADR) (NVO): Still a Buy, Despite the Tresiba Setback
Shares of Novo Nordisk A/S (NYSE:NVO) are trying to recover from a recent sell-off that occurred after the FDA rejected its new drug Tresiba -- citing lack of a pre-approval ...
Merck & Co., Inc. (MRK): A Global Health Care Giant Doling Out a Massive Dividend
A SWOT analysis is a look at a company’s strengths, weaknesses, opportunities, and threats, and is a tremendous way to gain a detailed and thorough perspective on a company ...
4 Orphan Drugs Making Waves in 2013: Sanofi SA (ADR) (SNY) and More
Orphan drugs -- medications meant for small patient populations with rare, dangerous diseases -- can be a rewarding business for biotech firms that strike gold.
Sanofi SA (ADR) (SNY)’s GLP-1 Accepted for Review by FDA
Sanofi SA (ADR) (NYSE:SNY) announced this week that the Food and Drug Administration began to review the company's once-daily type 2 diabetes injectable lixisenatide.
Are These 3 Stocks Down for the Count?: Ruckus Wireless Inc (RKUS) and More
Horse meat and Wal-Mart Stores, Inc.
Can Johnson & Johnson (JNJ)’s Zytiga Build on a Historic 2012?
Johnson & Johnson (NYSE:JNJ) may offer well-known personal-care products such as Listerine and Neutrogena, but it also boasts an impressive portfolio of market-leading therapeutic...
Biogen Idec Inc. (BIIB): A Strong Growth Opportunity In Multiple Sclerosis
Biogen Idec Inc.(NASDAQ:BIIB) has just moved to reinforce its dominance in the multiple sclerosis treatment market by striking a deal to buy the 50% rights to Tysabri that it...
BioMarin Pharmaceutical Inc. (BMRN) Earnings: An Early Look
Earnings season is now starting to wind down, with most companies already having reported their quarterly results.
Pfizer Inc. (PFE) and More: Should Big Pharma Follow the Spinoff Trend?
Pfizer Inc. (NYSE:PFE) faced a rough 2012 after Lipitor's loss of exclusivity in November 2011.
BioMarin Pharmaceutical Inc. (BMRN) is a Prime Takeover Target
How many of us as investors want to identify companies that are pioneers in their industry? Is it possible to find commonality across sectors, which factors make specific companies...
Better Buy: Pfizer Inc. (PFE) or Zoetis Inc (ZTS)?
Pfizer Inc. (NYSE:PFE) recently spun off animal health firm Zoetis Inc (NYSE:ZTS) in the form of an IPO.
Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Rule This Multibillion-Dollar Market?
Back in 2011, generic drug giant Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) dominated the MS field, riding the coattails of its Copaxone medication to success.
Merck & Co., Inc. (MRK)’s Crash of a Titan
Merck & Co., Inc. (NYSE:MRK)'s blockbuster asthma and allergy treatment Singulair fell off patent last year -- wiping more than 60% of revenue off the company's top line.
Warren Buffett’s Long-Term Dividend Holds: Sanofi SA (ADR) (SNY) and More
Warren Buffett has made a name for himself by snatching up companies at deep discounts and holding until he’s captured as much value as possible.
Can These 3 Stocks Be Resurrected?: Heckmann Corporation (HEK) and More
Lackluster trading was being blamed for the Dow Jones Industrial Average ticking down 21 points yesterday, gripped by ennui over both domestic and international financial woes...
What’s Moving These Biotech Stocks? – Novo Nordisk (NVO), Peregrine Pharmaceuticals (PPHM)
Typically, it doesn't take a lot for a stock to trade with gains/losses of more than 5% in a session; it can be caused by an analyst's remarks, sometimes it's caused by earnings...
We Love You, Just Not Enough to Buy You (Yet): Regeneron Pharmaceuticals Inc (REGN), Sanofi SA (SNY)
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) said Monday that it got a notice from its partner Sanofi SA (NYSE:SNY) saying that the pharma intends to buy additional shares of the...
The Best Dividend in Big Pharma: Sanofi SA (SNY), Pfizer Inc. (PFE), GlaxoSmithKline plc (GSK)
Big pharma's a good place to start if you're looking for dividend stocks.
Xerenex Kidney Treatment: A Game Changer for Keryx Biopharmaceuticals (KERX)
Keryx Biopharmaceuticals (NASDAQ:KERX)’s latest kidney drug called Zerenex is a game changer for the company after achieving positive results from its long-term Phase 3 study...
The Investor’s Guide to Zoetis Inc (ZTS): Pfizer Inc. (PFE), Merck & Co., Inc. (MRK)
Looking for the hottest name in health care? Right now it's not big pharma nor even a hot biotech firm making waves on Wall Street; it's newly minted animal health firm Zoetis...
High Dividend Yields for Billionaire Thomas Steyer’s Farallon Capital
Since founding Farallon Capital Management in 1986, Thomas Steyer and fellow investment manager Andrew J. M.
Sanofi SA (SNY) & ISIS Pharmaceuticals, Inc. (ISIS) Out-Limbo Aegerion Pharmaceuticals, Inc. (AEGR) in HoFH
I was admittedly never very good when it came to limbo because I'm not very flexible and I'm all legs. Sanofi SA (ADR) (NYSE:SNY) and ISIS Pharmaceuticals, Inc.
3 Things to Watch at Momenta Pharmaceuticals, Inc. (MNTA)
Despite its name, Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) has been losing steam since the end of 2011 with revenue falling 97% in the last nine months.
3 Stocks Laboring to Survive: Tellabs, Inc. (TLAB), Glu Mobile Inc. (GLUU) and More
The market had two ways to view Friday's employment numbers.
Sanofi SA (SNY)’s New Diabetes Play Moves Forward
Sanofi SA (ADR) (NYSE:SNY) starts the week with a new European Union approval for the type 2 diabetes injectable Lyxumia.
3 Ways to Make Money With Zoetis (Even If You Missed the IPO): Pfizer Inc. (PFE)
It's too late. If you wanted to buy into what has been hyped as the biggest IPO since Facebook Inc (NASDAQ:FB), but didn't, you missed your chance. Pfizer Inc.
Two Peas in a Pharma Pod: Pfizer Inc (PFE), Bristol Myers Squibb Co. (BMY)
Pfizer's 2012 revenue was down 10%; Bristol-Myers Squibb's was off by 17%. Both are down because of expirations of megablockbusters they used to own.
Buffett vs. Woodford: Who’s Winning on Tesco PLC (TSCO)?
LONDON -- This time last year, Warren Buffett, the famous billionaire U.S. investor, and Neil Woodford, the ace U.K.
Why Sanofi SA (NYSE:SNY) is Set for a Great 2013
Last year was a pretty good one for stockholders in Sanofi SA (NYSE:SNY), and the indications are that this year could be the same.
Billionaire Ken Fisher Thinks Pfizer Is Right For You
Billionaire Ken Fisher isn’t only the head of Fisher Asset Management, but also a long-running Forbes columnist whose picks published in that magazine have tended to outperform...
Pfizer, Johnson & Johnson, Merck: 10 Pharma Stocks Hedge Funds Love
After identifying the ten most popular stocks among hedge funds according to their third quarter 13F filings, we have decided to break down the top ten stocks that hedge funds...
Four High Yield Stocks From Warren Buffett’s Portfolio
Quarterly 13F filings disclose what hedge funds and other notable investors owned at the end of a quarter (which is about six or seven weeks ago by the time the 13Fs are generally...
iShares Strategist Upgrades France
On Monday, Moody's Investors Service stripped France, the eurozone's second-largest economy behind Germany, of the prestigious AAA credit rating.
